Clinical trial · Interventional
The Efficacy of Pain Management With Self-reporting Pain Monitoring System in Cancer Patient
The Efficacy of Pain Management With Self-reporting Pain Monitoring
NCT03117075CI-TRIAL-00027027painunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To compare the pain scales between clinician evaluated and reported with wearable device by patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| using device for scoring pain scale, named "ANAPA®" | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Experimental
- description
- using device for scoring pain scale, named "ANAPA®"
- interventionNames
- Device: using device for scoring pain scale, named "ANAPA®"
Primary outcomes (1)
- measure
- Actual difference of pain scales
- timeFrame
- 1 week after using wearable pain scale device - baseline and 1 week.
- description
- comparing the pain scale assessed by wearable device and that assessed by physician when out patient clinic.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * over 20 year old * cancer pain with visual analog scale or numeric rating scale score \>/- 4 * opioids candidates * with informed consent form Exclusion Criteria: * life expectancy within 3 months
References
Publications (0)
Data not yet available
No reference posted for this study.